Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)

✍ Scribed by Patrick Schöffski; Jean-Yves Blay; Jacques De Greve; Etienne Brain; Jean-Pascal Machiels; Jean-Charles Soria; Stefan Sleijfer; Pascal Wolter; Isabelle Ray-Coquard; Christel Fontaine; Gerd Munzert; Holger Fritsch; Gertraud Hanft; Claire Aerts; Jérome Rapion; Anouk Allgeier; Jan Bogaerts; Denis Lacombe

• Book ID: 116430386
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 657 KB
• Volume: 46
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2010.03.039